Lincoln Pharmaceuticals Ltd - LINCOLN PHARMA. Share Price

Sector: Pharmaceuticals | ISIN: INE405C01035
₹ 378.55 (-0.16%) icon5 Jun, 2023, 3:40:44 PM
Open
₹ 379.10
Prev. Close
₹ 379.15
Turnover(lac)
₹ 329.94
Day's High
₹ 383.20
Day's Low
₹ 377.00
52 Wk High
₹ 456.30
52 Wk Low
₹ 270.00
Book Value
₹ 252.51
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 758.23
P/E
10.40
EPS
36.40
Div. Yield
0.40

Lincoln Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 6/5/2023 3:40:44 PM

    ₹ 378.55 -0.60 -0.16
  • Open
  • ₹ 379.1
  • Prev. Close
  • ₹ 379.15
  • Turnover(Lac.)
  • ₹ 330
  • Day's High
  • ₹ 383.2
  • Day's Low
  • ₹ 377
  • 52 Week's High
  • ₹ 456.3
  • 52 Week's Low
  • ₹ 270
  • Book Value
  • ₹ 252.51
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 758.23
  • P/E
  • 10.4
  • EPS
  • 36.4
  • Divi. Yield
  • 0.4

Lincoln Pharmaceuticals Ltd Corporate Actions

15 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2023

12:00 AM

31 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2022

12:00 AM

26 Aug , 2022

12:00 AM

AGM

Announcement date: 26 Aug , 2022

View Details

19 May , 2022

12:00 AM

Dividend

Dividend amount: 1.5
Announcement date: 19 May , 2022

View Details

28 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2022

12:00 AM

26 Aug , 2022

12:00 AM

BookCloser

View Details

Lincoln Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
06 June , 2023 | 08:03 AM

PROMOTER - TOTAL47.00%

Indian: 47.00%

Foreign: 0%

NON-PROMOTER - TOTAL 53.00%

Institutions: 1.27%

Non-Institutions: 51.73%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Lincoln Pharmaceuticals Ltd News and Update

Image not found
  • 19 hours ago |
  • 5:49 PM

The Wonderla Holidays Ltd stock has delivered a return of 62.15 % over the past five years.

Image not found
Image not found
Image not found
ad IconAd Image

Lincoln Pharmaceuticals Ltd FINANCIALS

Lincoln Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Lincoln Pharmaceuticals Ltd

  • Kishorbhai M Shah
  • Chairman (Non-Executive)
  • Mahendra G Patel
  • Managing Director
  • Hasmukhbhai I Patel
  • Whole-time Director
  • Pirabhai R Suthar
  • Independent Director
  • Munjal Mahendrabhai Patel
  • Whole-time Director
  • Aashish R Patel
  • Whole-time Director
  • Meha Patel
  • Independent Director
  • Saurin J Parikh
  • Independent Director
  • Rajnikant G Patel
  • Director
  • Anand Arvindbhai Patel
  • Whole-time Director
  • Trusha Shah
  • Company Sec. & Compli. Officer

Summary

Lincoln Pharmaceuticals, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a partnership firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a public limited company in Jan. 95. All the assets and business of the erstwhile partnership was transferred to the company. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.96 to part-finance its project.In 2000-01 the company has been granted ISO 9002 certificate and WHO... Read More


Reports by Lincoln Pharmaceuticals Ltd


Reports by Lincoln Pharmaceuticals Ltd